Nabriva Therapeutics PLC (NASDAQ:NBRV)

0.7249
Delayed Data
As of 3:59pm ET
 -0.0091 / -1.24%
Today’s Change
0.49
Today|||52-Week Range
2.77
-45.08%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Nabriva Therapeutics PLC have a median target of 1.75, with a high estimate of 2.00 and a low estimate of 1.50. The median estimate represents a +141.41% increase from the last price of 0.72.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Hold stock in Nabriva Therapeutics PLC. This rating has held steady since July, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.10
Sales
$1.1M
Reporting Date
Nov 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 30.36%
 
 
 
 
 
 
Growthannually 51.07%
 
 
 
 
 
 

Sales

Growthquarterly 129.30%
 
 
 
 
 
 
Growthannually -2.15%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.